Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Phase I-II trial of sunitinib and/or nivolumab plus chemotherapy in advanced soft tissue and bone sarcomas Ended

2024-514776-40-00 Advanced soft tissue and bone sarcomas 9 2017-03-23
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection Ended

2024-510704-37-00 ER+/HER2- metastatic breast cancer 5 2017-03-22
Comparing two treatment regimen for sinuses tumors and salivary glands: radiotherapy versus chemoradiotherapy Ended

2024-513972-16-00 - Resected tumors of sinuses or salivary glands - Non-o 5 2017-01-30
A First-in-Human, Open-label, Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723… Ended

2023-506144-16-00 Advanced Stage Solid Tumors 7 2016-12-06
RISK OF INFERTILITY RELATED TO ADJUVANT CHEMOTHERAPY IN YOUNG BREAST CANCER PATIENTS: OOCYTE/EMBRYO CRYOPRESERVATION Ended

2024-513078-23-00 breast cancer in young women 4 2016-12-02
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study Ended

2023-510298-33-00 Prostate Cancer 4 2016-11-29
A Study of LY3200882 in Participants With Solid Tumors. Ended

2023-507177-17-00 Metastatic cancer 1 2016-11-21
Study of Abemaciclib with Pembrolizumab in Patients with Stage IV Lung Cancer or Breast Cancer Ended

2023-506788-32-00 Lung Cancer or Breast Cancer 2 2016-11-15
NEOadjuvant chemotherapy only compared with standard treatment for Locally Advanced Rectal cancer: a randomized phase II trial Ended

2024-517748-76-00 Rectum cancer 9 2016-11-14
A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer Ended

2023-507175-22-00 Metastatic Breast Cancer 4 2016-09-19
A Phase 1b, Multicenter, Open-label Study of Acalabrutinib in Combination with Bendamustine and Rituximab (BR) or Venetoclax and Rituximab (… Ended

2023-509353-31-00 Mantle Cell Lymphoma 2 2016-09-05
Bosutinib in pediatric CML patients Ended

2023-504311-32-00 Chronic Myeloid Leukemia 9 2016-09-02
DAHANCA 30: A randomized non-inferiority trial of hypoxia-profile guided hypoxic modification with nimorazole during radiotherapy/chemoradio… Ended

2024-516178-31-00 Head and neck squamous cell carcinoma (HNSCC) 5 2016-08-24
A study to decide what is the highest dose of CC-220 to take alone and with other standard of care treatments to assess the side effects, ef… Ended

2024-510799-19-00 Multiple Myeloma 9 2016-08-09
Study of Tumor Alterations Responsive to Targeting Receptor Kinases-2 Ended

2023-505034-10-00 Locally Advanced or Metastatic Solid Tumors that Harbor 4 2016-08-01
A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Ended

2024-512115-50-00 Relapsed/Refractory DLBCL 4 2016-06-22
A clinical trial in patients with advanced liver cancer. The trial will investigate the safety, tolerability and clinical activity of durval… Ended

2024-517085-41-00 Hepatocellular Carcinoma 4 2016-05-16
CheckMate 274 Ended

2022-500630-29-00 Subjects with High Risk Invasive Urothelial Carcinoma 5 2016-05-06
Adjuvant dendritic-cell immunotherapy plus temozolomide following surgery and chemoradiation in patients with newly diagnosed glioblastoma Ended

2024-515291-13-00 Glioblastoma grade IV 4 2016-04-01
Neoadjuvant L19IL2/L19TNF- Pivotal study Ended

2024-515749-40-00 Malignant melanoma of the skin in patients with locally 5 2016-02-25
PhII Trial of Pembrolizumab in Advanced Solid Tumors Ended

2022-501253-37-00 (A) Anal Squamous Cell Carcinoma, (B) Biliary Adenocarc 4 2016-02-02
An Efficacy and Safety Study of JNJ56021927 (ARN509) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS Ended

2023-505246-26-00 High- or very-high risk, localized or locally advanced 5 2016-01-27
A study for patients who have completed a prior global Novartis sponsored ceritinib (LDK378) study and are judged by the investigator to ben… Ended

2024-511040-58-00 non small cell lung cancer 6 2016-01-12
EORTC-1407-GUCG: A randomized phase III trial comparing conventional-dose chemotherapy using paclitaxel, ifosfamide, and cisplatin (TIP) wit… Ended

2024-513509-30-00 Progressive or recurrent germ cell tumor (measurable or 5 2016-01-11